Endocyte to Present at Jefferies Healthcare Conference
29 mai 2018 16h30 HE
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., May 29, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
Endocyte Announces Presentation of Phase 2 Data from Investigator-Initiated Prostate Cancer Trial of 177Lu-PSMA-617 at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
16 mai 2018 18h05 HE
|
Endocyte, Inc.
– PSA response rates in additional 20 mCRPC patients enrolled at Peter MacCallum Cancer Centre higher than previously reported for first group of 30 patients – – Company to host and webcast...
Endocyte Announces The Lancet Oncology Publication of Phase 2 Data From Investigator-Initiated Prostate Cancer Trial of (177)Lu-PSMA-617
09 mai 2018 08h01 HE
|
Endocyte, Inc.
-Publication includes analysis of original 30 patients previously presented at 2017 ESMO by Professor Michael Hofman of Peter MacCallum Cancer Centre- -Relative to previously presented...
Endocyte Provides First Quarter 2018 Financial Results and Operational Update
09 mai 2018 08h01 HE
|
Endocyte, Inc.
-Recently Updated Phase 2 Data on 177Lu-PSMA-617 Published in The Lancet Oncology Favorable to Preliminary Data Presented at 2017 ESMO Congress- -Positive End of Phase 2 FDA Meeting Set...
Endocyte Announces First Quarter 2018 Earnings Call
02 mai 2018 08h01 HE
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., May 02, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today...
Endocyte to Present at Deutsche Bank's 43rd Annual Health Care Conference
01 mai 2018 16h01 HE
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., May 01, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
Endocyte Presents Data from its CAR T Platform at American Association for Cancer Research (AACR) Annual Meeting 2018
16 avr. 2018 09h00 HE
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., April 16, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
Endocyte Announces Presentations at American Association for Cancer Research (AACR) Annual Meeting 2018
15 mars 2018 16h01 HE
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., March 15, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
Endocyte Nominates Dawn Svoronos for Election to Its Board of Directors and Announces Other Board Developments
15 mars 2018 08h01 HE
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., March 15, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
Endocyte to Present at the Cowen and Company 38th Annual Health Care Conference
05 mars 2018 16h01 HE
|
Endocyte, Inc.
WEST LAFAYETTE, March 05, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment , today announced that...